Speak with other shareholders about: (OTCBB: SUWN), (NYSE: KO), (NASDAQ: CHINA ), (NYSE: AOB)
AUSTIN, TX: June 13, 2007 – Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Now” button at the top.
Have you ever watched a STOCKUMENTARY? Click the following link to view your first ever full length STOCKUMENTARY: http://www.stockwire.com/cdrom/streaming_flash_page.htm .
----------------------------------------------------------
Talk to other SUWN shareholders by clicking the following link: http://www.stockwire.com
Sunwin Stevia International Corp., a wholly-owned subsidiary of Sunwin International Neutraceuticals, Inc (OTC BB: SUWN), announced yesterday that its OnlySweet line of products are now available for purchase at a wide variety of national grocery chains throughout the United States as the Company has completed its initial shipments. Only Sweet is a proprietary product line blended with Stevioside (stevia), a natural sweetener, extracted from the leaves of the Stevia rebaudiana plant. OnlySweet is blended in an FDA approved facility in the United States that provides similar services to some of the most highly recognized brands in the food industry. In addition, the company received Kosher certification in June of 2007.
In 2006, it was announced that Sunwin Stevia International Corp. had developed its OnlySweet line of products using its proprietary blend of stevia, formulated through extensive research and testing for consistency and flavor. The Company launched its website www.onlysweet.com, offering OnlySweet to the public in January 2007.
Now that initial shipments have been delivered, OnlySweet is available for purchase in several national grocery chains and will soon be available in over 30 states. The company's first order came from one of the largest grocery retailers in the United States, for distribution in their stores on a national rollout. The company has received numerous additional orders from other regional chains as Sunwin Stevia International Corp. continues to aggressively market the OnlySweet line of products and the Company expects additional outlets will be carrying the product throughout the year.
Working in concert with retailers and in response to their input, the Company has recently redesigned its packaging to highlight the "All Natural" attributes of OnlySweet. The Company and retailers believe the significant up-trend in the purchase of "All Natural" products will further differentiate OnlySweet from its competition and lead to increased sales.
OnlySweet is a proprietary blend that comes in 100 count and 200 count 1-gram packages. The company is currently working on a baking product that is scheduled to soon be available to consumers. The product is currently labeled as a dietary supplement in accordance with FDA requirements.
OnlySweet is blended in an FDA approved facility in the United States that provides similar services to some of the most highly recognized brands in the food industry. The facility ensures the highest levels of quality control protocol are performed on each and every run of our product. In addition, the stevia in OnlySweet maintains Kosher certification.
The stevia in OnlySweet comes from its parent company Sunwin International Neutraceuticals, Inc. (OTCBB SUWN), one of the world's largest stevia manufacturers and distributors. This ensures consistency and quality in every package of our product. We believe that OnlySweet is the best tasting stevia product on the market. Over a million Americans have used stevia products, and the majority of similar products available for sale are offered at a cost that is extremely high compared to OnlySweet. Our products will be priced 40% to 50% less than the majority of our competitors, therefore making it more affordable to the masses.
According to a report published by Wall Street Journal recently, Coca-Cola Company (NYSE: KO) and Cargill Inc. have teamed up to market a new calorie-free natural sweetener they hope will appeal to health-conscious consumers and shake up the global sweeteners market, but they face serious regulatory and production challenges.
Talk to other KO shareholders by clicking the following link: http://www.stockwire.com
The two companies' ambitious push to develop the new product, tentatively named rebiana, is the latest step in the soft-drink industry's decades-long quest for the "holy grail" of sweeteners -- one that sweetens products naturally, without adding calories, but also tastes good. Sucralose, the most recent breakthrough, was introduced in the U.S. in 2000 under the brand name Splenda.
Today, the multibillion-dollar global sweetener market is dominated by sugar, high-fructose corn syrup and synthetic sweeteners such as aspartame and sucralose. But with consumers increasingly eager for healthy foods and beverages of natural origin, Coke and Cargill may have found a sweet spot for rebiana, which is derived from a South American herb called stevia.
Coke, the Atlanta beverage giant, has quietly filed 24 patent applications that were published by the U.S. Patent and Trademark Office last week and says it will have exclusive rights to develop and sell rebiana in beverages. Closely held Cargill, the big Minneapolis food and agriculture company, plans to market the sweetener for use in products such as yogurt, cereals, ice cream and candy, and hasn't ruled out selling it for tabletop use.
----------------------------------------------------------
Talk to other CHINA shareholders by clicking the following link: http://www.stockwire.com
CDC Corporation (NASDAQ: CHINA), a leading Global Enterprise Software and New Media Company, today announced that it is opening a new development center in Nanjing, China that will house more than 2,000 employees when fully staffed.
The development center's focus will provide cost-effective development capabilities for CDC Software and CDC Games, and will be a key technology center supporting software products, online games development, centralized quality assurance and testing, and support services. The center will also provide a wide variety of outsource and managed services including network security management, database management, network infrastructure design, help desk and call center support services.
----------------------------------------------------------
Talk to other AOB shareholders by clicking the following link: http://www.stockwire.com
American Oriental Bioengineering (NYSE: AOB) announced yesterday the signing of a letter of intent to acquire Changchun Xinan Pharmaceutical Group Company Limited (CCXA), a privately owned plant based pharmaceutical company in a transaction the company expects not to exceed US$30 million. Pursuant to the terms of the letter of intent, AOB has 90 days to enter into a definitive purchase agreement and close the transaction with CCXA. The company anticipates the consideration for the acquisition will be all in cash.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
Stockwire Research Group, Inc. .
512.358.8440 .
info@stockwire.com .
